Will Kaiser pay for this? Kirk Nielsen of Versant Ventures said that has become the litmus test for healthcare investing in the new world of healthcare reform. An “early stage vs. late stage” panel at today’s MedTech Investing conference in Minneapolis showed how venture capitalists of all types are changing their evaluation process as healthcare […]
Behold, convergence. A startup backed by the likes of Medtronic and Novartis has combined sensors with mobile technology, pharmaceuticals and medical devices to develop what’s being hyped as the U.S.’s first smart pill system. Just cleared by the U.S. Food and Drug Administration, Proteus Digital Health‘s tiny ingestible sensor is used with a companion wearable […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The hypertension treatment market is hot, with Medtronic leading the way in commercializing a renal denervation device. An estimated two dozen other companies are chasing the medical device heavyweight using the same approach, and today another startup announced that it raised a $30 million series C to add staff and fund clinical trials of its […]
ATS Medical Inc. (NASDAQ:ATSI) stock has been a dog for quite a while, never rising above $5 a share since 2004. Yet some investors stand to profit handsomely from Medtronic Inc.’s (NYSE:MDT) proposed $370 million acquisition of the company. In 2007, ATS Medical, desperate for cash, sold stock to San Francisco venture capital firm Alta […]
White Pine Medical is in the midst of a $57 million equity fundraise that will power its first medical devices fund, according to a Securities and Exchange Commission filing. White Pine is affiliated with Essex Woodlands Health Ventures, a venture powerhouse that was founded in 1985, has raised eight funds and has about $2.5 billion […]
OrbiMed Advisors, which has invested in Ohio companies Athersys Inc. and ViewRay, has raised $550 million for its latest health venture capital fund.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Dan Lemaitre will lead the new White Pine Medical fund, which will receive a financing commitment of "up to" $50 million from Essex Woodlands Health Ventures.
The company will use the funding to expand its sales and customer support teams, and prepare to launch its sinus-treatment system in Europe.
Essex Woodlands Health Ventures' eighth fund closed at $900 million - one of the largest ever for a health-care-only fund. At the same time, Google Ventures said its portfolio will include health-care, biotech and cleantech companies. It wants to invest $100 million in the next 12 months.